AbbVie · 1 week ago
2026 Parenteral Bioanalytical Intern (PDS&T) (PhD)
AbbVie is a pharmaceutical company dedicated to discovering and delivering innovative medicines and solutions. The Parenteral Bioanalytical Intern will work with dynamic light scattering techniques to analyze protein samples and assess their aggregation, contributing to the development of analytical methods in the bioanalytical laboratory.
BiotechnologyFinancial ServicesHealth CareMedicalPharmaceuticalVenture Capital
Responsibilities
Utilize the dynamic light scattering instrument in the bioanalytical laboratory
Prepare antibody samples with varying levels of aggregation
Analyze samples using both dynamic light scattering and SEC assays
Assess the correlation between results from dynamic light scattering and SEC assays
Qualification
Required
Enrolled currently in university, pursuing a PhD in Analytical Chemistry, Chemical Engineering, Materials Science and Engineering, Biomedical Engineering, Pharmaceutical Engineering, or other related fields
Must be enrolled in university for at least one semester following the internship
Experience with protein analysis techniques such as: SEC-HPLC
Preferred
Expected graduation date between December 2026 – July 2027
Knowledge of dynamic light scattering is a plus
Strong communication and teamwork skills
Demonstrated leadership and adaptability
Effective problem-solving and time management abilities
Benefits
Competitive pay
Relocation support for eligible students
Select wellness benefits and paid holiday / sick time
Company
AbbVie
AbbVie is a biopharmaceutical company focused on immunology, oncology, neuroscience, virology, and aesthetics. It is a sub-organization of AbbVie.
H1B Sponsorship
AbbVie has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (273)
2024 (190)
2023 (225)
2022 (284)
2021 (186)
2020 (186)
Funding
Current Stage
Public CompanyTotal Funding
$15B2024-02-27Post Ipo Debt· $15B
2023-03-08Post Ipo Equity· $0.25M
2012-12-20IPO
Leadership Team
Recent News
2026-01-08
Morningstar.com
2026-01-08
Company data provided by crunchbase